Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Deciphering the Roles of Transcription Elongation Factors in the Development of Cardiac Hypertrophy

FY 2014-15

Summary
Cardiomyocytes, the individual contractile units of the heart, increase in size following periods of continuous stress to the heart in hypertension or following a heart attack. The enlargement of these cells, termed cardiac hypertrophy, initially improves cardiac function as a compensatory mechanism. However, prolonged stress and continued increase in cell size can lead to cell damage and eventually heart failure due to death of these cardiomyocytes. In cardiomyocytes, an overall increase in RNA synthesis and protein production as these cells enlarge coincides with an increase in the activity of the protein positive transcription elongation factor b (P-TEFb). Interestingly, previous studies have shown that inhibition of P-TEFb can prevent cardiac hypertrophy. My project will focus on elucidating the mechanisms acting both upstream and downstream of P-TEFb activity in hypertrophic cardiomyocytes. We hypothesize that interventions that alter these mechanisms can be exploited to decrease the cardiomyocyte hypertrophic response. Expression of proteins known to participate in P-TEFb-dependent pathways will be knocked down in primary cardiomyocytes, to determine their specific roles in cardiomyocyte enlargement. We will also determine how decreased levels of these proteins affects global changes in genomic expression observed in hypertrophic cardiomyocytes. Results obtained from this study will enhance our understanding of how P-TEFb functions in the heart under disease conditions and may also identify potential therapeutic targets for the treatment of heart disease.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331431
Name
Martin Ryan
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Deciphering the Roles of Transcription Elongation Factors in the Development of Cardiac Hypertrophy
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Elongation; Heart; Hypertrophy; Knockdown; Myocyte; P-Tefb; Primary Cell Line; Rna Polymerase Ii; Shrna; Transcription
Abstract
Cardiomyocytes, the individual contractile units of the heart, increase in size following periods of continuous stress to the heart in hypertension or following a heart attack. The enlargement of these cells, termed cardiac hypertrophy, initially improves cardiac function as a compensatory mechanism. However, prolonged stress and continued increase in cell size can lead to cell damage and eventually heart failure due to death of these cardiomyocytes. In cardiomyocytes, an overall increase in RNA synthesis and protein production as these cells enlarge coincides with an increase in the activity of the protein positive transcription elongation factor b (P-TEFb). Interestingly, previous studies have shown that inhibition of P-TEFb can prevent cardiac hypertrophy. My project will focus on elucidating the mechanisms acting both upstream and downstream of P-TEFb activity in hypertrophic cardiomyocytes. We hypothesize that interventions that alter these mechanisms can be exploited to decrease the cardiomyocyte hypertrophic response. Expression of proteins known to participate in P-TEFb-dependent pathways will be knocked down in primary cardiomyocytes, to determine their specific roles in cardiomyocyte enlargement. We will also determine how decreased levels of these proteins affects global changes in genomic expression observed in hypertrophic cardiomyocytes. Results obtained from this study will enhance our understanding of how P-TEFb functions in the heart under disease conditions and may also identify potential therapeutic targets for the treatment of heart disease.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Martin, Ryan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~